Analysts fell to the sidelines weighing in on Sanofi (SNYNF – Research Report), Zymeworks (ZYME – Research Report) and Twist Bioscience (TWST – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Sanofi (SNYNF)
UBS analyst Michael Leuchten maintained a Hold rating on Sanofi today and set a price target of EUR92.00. The company’s shares closed last Friday at $87.60.
According to TipRanks.com, Leuchten is ranked #2204 out of 8112 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sanofi with a $104.32 average price target.
See the top stocks recommended by analysts >>
Zymeworks (ZYME)
H.C. Wainwright analyst Robert Burns reiterated a Hold rating on Zymeworks today and set a price target of $10.00. The company’s shares closed last Friday at $7.76.
According to TipRanks.com, Burns has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Zymeworks with a $12.17 average price target, representing a 51.9% upside. In a report issued on November 9, SVB Securities also maintained a Hold rating on the stock with a $8.00 price target.
Twist Bioscience (TWST)
SVB Securities analyst Puneet Souda maintained a Hold rating on Twist Bioscience today and set a price target of $30.00. The company’s shares closed last Friday at $24.81, close to its 52-week low of $23.90.
According to TipRanks.com, Souda has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Twist Bioscience with a $36.25 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SNYNF:
- Victory Bancorp, Inc. Announces Quarterly Cash Dividend
- New Buy Rating for Microsoft (MSFT), the Technology Giant
- Aurora Spine Corporation Announces Third Quarter Fiscal 2022 Financial Results
- Boralex commissions the first repowered wind farm in the French department of Somme
- Anfield Expands its Artillery Peak Uranium Project and Commissions BRS Inc. to Complete a Uranium Resource Report
